Phoenix, AZ, United States of America

Emmett Manuel Cunningham

USPTO Granted Patents = 12 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Phoenix, AZ (US) (2009 - 2014)
  • Hillsborough, CA (US) (2017 - 2019)
  • Hillsboro, CA (US) (2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Emmett Manuel Cunningham: A Trailblazer in Innovation

Introduction:

Emmett Manuel Cunningham, a standout figure in the world of inventors, hails from Phoenix, AZ (US). With a total of 12 patents to his name, Cunningham's dedication to pushing the boundaries of innovation and relentless pursuit of excellence have solidified his place as a visionary in the field.

Latest Patents:

Cunningham's latest patents revolve around the development of drugs and compositions for the treatment of ocular disorders. These include the creation of new prodrugs of therapeutically active compounds and compositions aimed at addressing medical disorders such as glaucoma, neuroprotection, age-related macular degeneration, and diabetic retinopathy.

Career Highlights:

Throughout his illustrious career, Cunningham has made significant contributions that continue to inspire and shape the future of technology. He has been instrumental in the advancement of treatments for ocular disorders, showcasing his innovative mindset and commitment to improving healthcare outcomes.

Collaborations:

Cunningham has collaborated with esteemed professionals in the industry, including Jeffrey L Cleland and Ming Yang. Together, they have worked towards developing cutting-edge solutions and driving innovation in the medical field.

Conclusion:

Emmett Manuel Cunningham's unwavering dedication to innovation and his groundbreaking work in the realm of ocular disorder treatments highlight his status as a trailblazer in the field of inventors. His contributions not only make a difference today but also pave the way for future advancements in technology and healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…